miR-203 Regulates Cell Proliferation through Its Influence on Hakai Expression
Vanessa Abella(Complexo Hospitalario Universitario A Coruña), Angélica Figueroa(Universidade da Coruña), Luís Antón Aparicio(Universidade da Coruña), Mar Haz‐Conde(Complexo Hospitalario Universitario A Coruña), Nuria Tarrío(Marqués de Valdecilla University Hospital), Pilar Vieiro Iglesias(Complexo Hospitalario Universitario A Coruña), M. Blanco(Hospital Universitari de Girona Doctor Josep Trueta), Manuel Valladares(American Society of Clinical Oncology), T Veliz Rodriguez(Complexo Hospitalario Universitario A Coruña)
Cited by 41
Related Papers
Cancer drug resistance induced by EMT: novel therapeutic strategies
|Archives of Toxicology|2021|220
First-Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single-Agent Bevacizumab as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: The Phase III MACRO TTD Study
|The Oncologist|2012|213
The clinical–DWI mismatch
|Neurology|2004|207
Potential Role of Sugar Transporters in Cancer and Their Relationship with Anticancer Therapy
|International Journal of Endocrinology|2010|175